Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Agilent Technologies' Genomic DNA ScreenTape

Premium

Agilent Technologies has launched Genomic DNA ScreenTape, a prepackaged consumables device that works with the company’s 2200 TapeStation instrument to determine the quantity, size and quality of genomic DNA in less than two minutes per sample, using one microliter of material.

The company said in a statement that the new product addresses an "important bottleneck" in the quality assessment of genomic DNA, and demonstrates Agilent's commitment to "expanding the range of automated sample QC tools for next-generation sequencing and workflows for array comparative genome hybridization."

Agilent gained the ScreenTape technology and TapeStation instrument when it acquired Edinburgh, UK-based Lab901 two years ago (BAN 3/1/2011).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.